Finward Bancorp’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Sell
10,503
-50
-0.5% -$11.7K 2.02% 12
2026
Q1
$2.58M Sell
10,553
-8
-0.1% -$1.86K 2.06% 13
2025
Q4
$2.19M Sell
10,561
-11
-0.1% -$2.17K 1.7% 14
2025
Q3
$1.96M Sell
10,572
-226
-2% -$38.7K 1.49% 17
2025
Q2
$1.65M Buy
10,798
+109
+1% +$16.8K 1.3% 19
2025
Q1
$1.77M Sell
10,689
-59
-0.5% -$9.23K 1.54% 15
2024
Q4
$1.55M Buy
+10,748
New +$1.67M 1.35% 18

Other funds holding JNJ

Finward Bancorp's JNJ Position: Q2 2026 in Review

Finward Bancorp reduced its Johnson & Johnson (JNJ) stake by 0.47% in Q2 2026, selling an estimated $11.7K and leaving 10,503 shares worth $2.67M. The position accounts for 2.02% of the portfolio, ranked #12.

Finward Bancorp first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Finward Bancorp held 10,503 shares of Johnson & Johnson worth $2.67M as of Q2 2026.
  • Finward Bancorp sold 50 Johnson & Johnson shares in Q2 2026, an estimated $11.7K.
  • Johnson & Johnson made up 2.02% of Finward Bancorp's portfolio in Q2 2026, its #12 holding.
  • Finward Bancorp first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Finward Bancorp's 13F filing for Q2 2026, filed 16 Jul 2026.